This study is a 21-day supervised in-use test with 20 volunteers, conducted under the oversight of a qualified gynecologist. The study includes clinical evaluation and final gynecologist sign-off, providing medically supervised data on product tolerance and performance in the intimate area.
Because products intended for intimate use require a higher level of safety assessment, this study is designed to evaluate real-world use conditions while maintaining clinical control.
This study evaluates how a product performs when used on the intimate area over time. It focuses on:
It also helps determine whether repeated use may lead to irritation or discomfort.
The study follows a controlled, supervised in-use design over 21 days at a clinical site.
This structure ensures results reflect real product use while maintaining medical oversight.
Participants are adult female volunteers selected based on the intended product use.
All participants:
This ensures that observed effects are attributable to the product.
Clinical and subjective evaluations are performed throughout the study.
Clinical assessments may include:
Participants also complete structured questionnaires to document:
Both clinical observations and user feedback are included in the final evaluation.
This study can support a range of marketing and safety claims, including:
Final claim support depends on study outcomes and regulatory context.
At the conclusion of the study:
The report is suitable for use in safety documentation, product dossiers, and marketing support.
Pentyl Labs coordinates supervised in-use testing with:
We also support related services such as HRIPT, safety assessments, and claims substantiation, allowing results to fit seamlessly into your product development and compliance strategy.
Contact [email protected] to request a Supervised In-Use Test under Gynecological Control.